A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.
- DNA in fringe-lipped bat poop reveals unexpected eating habits
- DrugCell: new experimental AI platform matches tumor to best drug combo
- Coronavirus mutations show early safety measures and restrictions limited viral spread
- Artificial intelligence can now predict students’ educational outcomes based on tweets
- Tel Aviv University researchers discover molecular link between diet and risk of cancer